Juan Eduardo Megías-Vericat (Juan Eduardo Megías Vericat, J E Megías-Vericat, Juan Eduardo Megias-Vericat)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 28

Top Topics

Acute Myeloid Leukemia

Allogeneic Hematopoietic Stem Cell Transplantation

Newly Diagnosed

Top Venues

Haemophilia : the official journal of the World Federation of Hemophilia

Expert review of clinical pharmacology

Leukemia & lymphoma

This page only lists publications with an associated author ORCID identifier.

Publications

Sofía Pérez-Alenda, Juan J Carrasco-Fernandez, Felipe Querol-Fuentes, Juan Eduardo Megías-Vericat, Felipe Querol-Giner, María Luz Sánchez-Sánchez, Santiago Bonanad, Rodrigo Núñez-Cortés
Benefits of physical activity self-monitoring in patients with haemophilia: a prospective study with one-year follow-up. Haemophilia : the official journal of the World Federation of Hemophilia 30 (3) (2024)
Sofía Pérez-Alenda, Juan J Carrasco-Fernandez, Felipe Querol-Fuentes, Juan Eduardo Megías-Vericat, Felipe Querol-Giner, María Luz Sánchez-Sánchez, Santiago Bonanad, Rodrigo Núñez-Cortés
Benefits of physical activity self-monitoring in patients with haemophilia: a prospective study with one-year follow-up. Haemophilia : the official journal of the World Federation of Hemophilia (2024)
Sofía Pérez-Alenda, Juan J Carrasco-Fernandez, Felipe Querol-Fuentes, Juan Eduardo Megías-Vericat, Felipe Querol-Giner, María Luz Sánchez-Sánchez, Santiago Bonanad, Rodrigo Núñez-Cortés
Benefits of physical activity self-monitoring in patients with haemophilia: a prospective study with one-year follow-up. Haemophilia : the official journal of the World Federation of Hemophilia 30 (3) (2024)
Antonio Solana-Altabella, Juan Eduardo Megías-Vericat, Octavio Ballesta-López, David Martínez-Cuadrón, Pau Montesinos
Drug-drug interactions associated with FLT3 inhibitors for acute myeloblastic leukemia: current landscape. Expert review of clinical pharmacology 16 (2) (2023)
Antonio Solana-Altabella, Juan Eduardo Megías-Vericat, Octavio Ballesta-López, David Martínez-Cuadrón, Pau Montesinos
Drug-drug interactions associated with FLT3 inhibitors for acute myeloblastic leukemia: current landscape. Expert review of clinical pharmacology (2023)
Antonio Solana-Altabella, Juan Eduardo Megías-Vericat, Octavio Ballesta-López, David Martínez-Cuadrón, Pau Montesinos
Drug-drug interactions associated with FLT3 inhibitors for acute myeloblastic leukemia: current landscape. Expert review of clinical pharmacology (2023)
Antonio Solana-Altabella, Juan Eduardo Megías-Vericat, Octavio Ballesta-López, David Martínez-Cuadrón, Pau Montesinos
Drug-drug interactions associated with FLT3 inhibitors for acute myeloblastic leukemia: current landscape. Expert review of clinical pharmacology 16 (2) (2023)
Blanca Boluda, Antonio Solana-Altabella, Isabel Cano, David Martínez-Cuadrón, Evelyn Acuña-Cruz, Laura Torres-Miñana, Rebeca Rodríguez-Veiga, Irene Navarro-Vicente, David Martínez-Campuzano, Raquel García-Ruiz, Pilar Lloret, Pedro Asensi, Ana Osa-Sáez, Jaume Aguero, María Rodríguez-Serrano, Francisco Buendía-Fuentes, Juan Eduardo Megías-Vericat, Beatriz Martín-Herreros, Eva Barragán, Claudia Sargas, Maribel Salas, Margaret Wooddell, Charles Dharmani, Miguel Angel Sanz, Javier de la Rubia, Pau Montesinos
Incidence and Risk Factors for Development of Cardiac Toxicity in Adult Patients with Newly Diagnosed Acute Myeloid Leukemia. Cancers 15 (8) (2023)
Blanca Boluda, Antonio Solana-Altabella, Isabel Cano, David Martínez-Cuadrón, Evelyn Acuña-Cruz, Laura Torres-Miñana, Rebeca Rodríguez-Veiga, Irene Navarro-Vicente, David Martínez-Campuzano, Raquel García-Ruiz, Pilar Lloret, Pedro Asensi, Ana Osa-Sáez, Jaume Aguero, María Rodríguez-Serrano, Francisco Buendía-Fuentes, Juan Eduardo Megías-Vericat, Beatriz Martín-Herreros, Eva Barragán, Claudia Sargas, Maribel Salas, Margaret Wooddell, Charles Dharmani, Miguel Angel Sanz, Javier de la Rubia, Pau Montesinos
Incidence and Risk Factors for Development of Cardiac Toxicity in Adult Patients with Newly Diagnosed Acute Myeloid Leukemia. Cancers 15 (8) (2023)
Antonio Solana-Altabella, Octavio Ballesta-López, Juan Eduardo Megías-Vericat, David Martínez-Cuadrón, Pau Montesinos
Emerging FLT3 inhibitors for the treatment of acute myeloid leukemia. Expert opinion on emerging drugs 27 (1) (2022)
Antonio Solana-Altabella, Juan Eduardo Megías-Vericat, Octavio Ballesta-López, Blanca Boluda, Isabel Cano, Evelyn Acuña-Cruz, Rebeca Rodríguez-Veiga, Laura Torres-Miñana, Claudia Sargas, Miguel Angel Sanz, Carmela Borrell-García, Eduardo López-Briz, José Luis Poveda-Andrés, Javier de la Rubia, Pau Montesinos, David Martínez-Cuadrón
Healthcare Resource Utilization among Patients between 60-75 Years with Secondary Acute Myeloid Leukemia Receiving Intensive Chemotherapy Induction: A Spanish Retrospective Observational Study. Cancers 14 (8) (2022)
Juan Eduardo Megías-Vericat, David Martínez-Cuadrón, Antonio Solana-Altabella, José Luis Poveda-Andrés, Pau Montesinos
Systematic Review of Pharmacogenetics of ABC and SLC Transporter Genes in Acute Myeloid Leukemia. Pharmaceutics 14 (4) (2022)
Blanca Boluda, Antonio Solana-Altabella, Isabel Cano, Evelyn Acuña-Cruz, Rebeca Rodríguez-Veiga, Octavio Ballesta-López, Juan Eduardo Megías-Vericat, David Martínez-Cuadrón, Ines Gómez, Pilar Solves, Ignacio Lorenzo, Jose Luis Piñana, Jaime Sanz, Manuel Guerreiro, Juan Montoro Gómez, Alvaro Díaz-González, Javier Marco, Albert Blanco, Miguel Angel Sanz, Pau Montesinos
Extracorporeal photopheresis vs standard therapies for steroid-refractory chronic graft-vs-host disease: Pharmacoeconomic assessment of hospital resource use in Spain. Journal of clinical apheresis 36 (4) (2021)
Ruben Iglesias Gomez, Raúl Méndez, Tomás Palanques-Pastor, Octavio Ballesta-López, Conxa Borrás Almenar, Juan Eduardo Megías-Vericat, Eduardo López-Briz, Isabel Font-Noguera, Rosario Menéndez Villanueva, José Andrés Román Iborra, José Luis Poveda Andrés
Baricitinib against severe COVID-19: effectiveness and safety in hospitalised pretreated patients. European journal of hospital pharmacy : science and practice (2021)
David Martínez-Cuadrón, Juan Eduardo Megías-Vericat, Josefina Serrano, Pilar Martínez-Sánchez, Eduardo Rodríguez-Arbolí, Cristina Gil, Eliana Aguiar, Juan-Miguel Bergua, Jose L Lopez-Lorenzo, Teresa Bernal, Ana Espadana, Mercedes Colorado, Carlos Rodríguez-Medina, María López-Pavia, Mar Tormo, Jesus Lorenzo Algarra, Maria Luz Amigo, Maria Jose Sayas, Jorge Labrador, Juan I Rodríguez-Gutiérrez, Celina Benavente Cuesta, Lissette Costilla-Barriga, Raimundo García-Boyero, Esperanza Lavilla-Rubira, Susana Vives, Pilar Herrera, Daniel García Belmonte, María Mar Herráez-Albendea, Graça V Esteves, María Isabel Gómez-Roncero, Ana Cabello, Guiomar Bautista, Amaia Balerdi, José Mário Mariz, Blanca Boluda, Miguel A Sanz, Pau Montesinos
Treatment patterns and outcomes of 2310 patients with secondary acute myeloid leukemia: a PETHEMA registry study. Blood advances (2021)
María P Martínez Sánchez, Juan Eduardo Megías-Vericat, Rebeca Rodríguez-Veiga, Susana Vives, Juan Miguel Bergua, Anna Torrent, Sara Suárez-Varela, Blanca Boluda, Joaquín Martínez-López, Isabel Cano-Ferri, Evelyn Acuña-Cruz, Laura Torres-Miñana, Beatriz Martín-Herreros, Alfons Serrano, Amparo Sempere, Eva Barragán, Claudia Sargas, Miguel Sanz, David Martínez-Cuadrón, Pau Montesinos, null null
A phase I trial of selinexor plus FLAG-Ida for the treatment of refractory/relapsed adult acute myeloid leukemia patients. Annals of hematology 100 (6) (2021)
Tomás Palanques-Pastor, Juan Eduardo Megías-Vericat, Pilar Martínez, José Luis López Lorenzo, Javier Cornago Navascués, Gabriela Rodriguez Macias, Isabel Cano, Montserrat Arnan Sangerman, María Belén Vidriales Vicente, Jesús Lorenzo Algarra Algarra, María Ángeles Foncillas, Pilar Herrera, Carmen Botella Prieto, Susana Vives, Ángela Figuera Álvarez, Laida Cuevas Palomares, Marta Anna Sobas, Alejandro Contento Gonzalo, Rebeca Cuello García, María Elena Amutio Diez, Dunia De Miguel Llorente, Begoña Navas Elorza, Juan-Miguel Bergua, Teresa Bernal Del Castillo, María Carmen Mateos Rodríguez, Erik de Cabo López, Ana Carolina Franco Villegas, Raimundo García Boyero, Cristian Escolano Escobar, Cristina Seri Merino, Carlos Cervero, Alicia Roldán Pérez, Lourdes Hermosín Ramos, Marta Cervera Calvo, María Telesa Olave, Paola Villafuerte Gutiérrez, Almudena de Laiglesiai, Josefina Serrano, María Josefa Najera Irazu, José Luis Piñana, Miguel Ángel Sanz, Joaquin Martinez Lopez, Pau Montesinos
Characteristics, clinical outcomes, and risk factors of SARS-COV-2 infection in adult acute myeloid leukemia patients: experience of the PETHEMA group. Leukemia & lymphoma 62 (12) (2021)
Blanca Boluda, David Martínez-Cuadrón, Lorenzo Algarra, Isabel Cano, María J Sayas, Evelyn Acuña-Cruz, Albert Blanco, Javier Marco-Ayala, Rosalía DeLapuerta, Álvaro Díaz-González, María Del Mar Tormo Díaz, Rebeca Rodriguez-Veiga, Raimundo García, José Luis Piñana, María López-Pavía, Eva Barragán, María L Amigo, Claudia Sargas, Aurelio López, Antonio Solana-Altabella, Cristina Gil, Juan Eduardo Megías-Vericat, Miguel Angel Sanz, Pau Montesinos
Evolving patterns of care and outcomes in relapsed/refractory FLT3 mutated acute myeloid leukemia adult patients. Leukemia & lymphoma 62 (11) (2021)
Octavio Ballesta-López, Antonio Solana-Altabella, Juan Eduardo Megías-Vericat, David Martínez-Cuadrón, Pau Montesinos
Gilteritinib use in the treatment of relapsed or refractory acute myeloid leukemia with a FLT3 mutation. Future oncology (London, England) 17 (2) (2020)
Andreas Tiede, Santiago Bonanad, Amparo Santamaria, Georg Goldmann, Mariana Canaro, Antonio Palomero, Luis J G Frade, Juan Eduardo Megías-Vericat, Maria Fernanda Martinez Garcia, Faustino Garcia Candel, Victor Jimenez Yuste, Monika Sparber-Sauer, Susan Halimeh, Daniela Adolf, Martin Hukauf, Jan Reichmann, Johannes Oldenburg
Quality of electronic treatment records and adherence to prophylaxis in haemophilia and von Willebrand disease: Systematic assessments from an electronic diary. Haemophilia : the official journal of the World Federation of Hemophilia 26 (6) (2020)
Juan Eduardo Megías-Vericat, David Martínez-Cuadrón, María José Herrero, Rebeca Rodríguez-Veiga, Antonio Solana-Altabella, Blanca Boluda, Octavio Ballesta-López, Isabel Cano, Evelyn Acuña-Cruz, José Cervera, José Luis Poveda, Miguel Angel Sanz, Salvador F Aliño, Pau Montesinos
Impact of combinations of single-nucleotide polymorphisms of anthracycline transporter genes upon the efficacy and toxicity of induction chemotherapy in acute myeloid leukemia. Leukemia & lymphoma 62 (3) (2020)
Manuel Rodríguez López, Juan Eduardo Megías-Vericat, Carmen Albo López, Saturnino Haya Guaita
Clinical, pharmacokinetic and economic analysis of the first switch to an extended half-life factor IX (albutrepenonacog alfa, rFIX-FP) in Spain. BMJ case reports 13 (10) (2020)
Juan Eduardo Megías-Vericat, Antonio Solana-Altabella, Octavio Ballesta-López, David Martínez-Cuadrón, Pau Montesinos
Drug-drug interactions of newly approved small molecule inhibitors for acute myeloid leukemia. Annals of hematology 99 (9) (2020)
Juan Eduardo Megías-Vericat, David Martínez-Cuadrón, Antonio Solana-Altabella, Pau Montesinos
Precision medicine in acute myeloid leukemia: where are we now and what does the future hold? Expert review of hematology 13 (10) (2020)
Juan Eduardo Megías-Vericat, Octavio Ballesta-López, Eva Barragán, Pau Montesinos
IDH1-mutated relapsed or refractory AML: current challenges and future prospects. Blood and lymphatic cancer : targets and therapy 9 (2019)
Juan Eduardo Megías-Vericat, David Martínez-Cuadrón, Miguel Ángel Sanz, José Luis Poveda, Pau Montesinos
Daunorubicin and cytarabine for certain types of poor-prognosis acute myeloid leukemia: a systematic literature review. Expert review of clinical pharmacology 12 (3) (2019)
Juan Eduardo Megías-Vericat, Santiago Bonanad, Saturnino Haya, Ana Rosa Cid, María Remedios Marqués, Emilio Monte-Boquet, Sofía Pérez-Alenda, Pau Bosch, Felipe Querol, José Luis Poveda
Cross-sectional comparative study of pharmacokinetics and efficacy between sucrose-formulated recombinant factor VIII (Kogenate® ) and BAY 81-8973 (Kovaltry® ) in patients with severe or moderate haemophilia A in prophylaxis. Haemophilia : the official journal of the World Federation of Hemophilia 25 (3) (2019)
Juan Eduardo Megías-Vericat, E Monte-Boquet, M Martín-Cerezuela, M J Cuéllar-Monreal, M V Tarazona-Casany, P Pérez-Huertas, S Bonanad, J L Poveda-Andrés
Pilot evaluation of home delivery programme in haemophilia. Journal of clinical pharmacy and therapeutics 43 (6) (2018)